Xtandi

Product manufactured by Astellas Pharma Us, Inc.

Application Nr Approved Date Route Status External Links
NDA203415 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Xtandi ® Is Indicated For The Treatment Of Patients With: • Castration-Resistant Prostate Cancer (Crpc) • Metastatic Castration-Sensitive Prostate Cancer (Mcspc). Xtandi Is An Androgen Receptor Inhibitor Indicated For The Treatment Of Patients With: • Castration-Resistant Prostate Cancer. ( 1 ) • Metastatic Castration-Sensitive Prostate Cancer. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Enzalutamide ENZALUTAMIDE ZINC34806477

Comments